Griet Nijs unpaid staff Publications Griet Nijs Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ONE - ISSN 1932-6203-19:7 …

Griet Nijs onbezoldigd medewerker Publicaties Griet Nijs Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron PLoS ONE - ISSN 1932-620…